| Product NDC: | 0023-9321 |
| Proprietary Name: | ALPHAGAN P |
| Non Proprietary Name: | brimonidine tartrate |
| Active Ingredient(s): | 1 mg/mL & nbsp; brimonidine tartrate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0023-9321 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021770 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060125 |
| Package NDC: | 0023-9321-05 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-9321-05) > 5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 0023-9321-05 |
| Proprietary Name | ALPHAGAN P |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-9321-05) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0023-9321 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | brimonidine tartrate |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20060125 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | BRIMONIDINE TARTRATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |